Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;48(6):638-645.
doi: 10.1111/apt.14920. Epub 2018 Aug 1.

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study

Carl Eriksson  1 , Ida Henriksson  1 , Ole Brus  2 , Yaroslava Zhulina  1 , Nils Nyhlin  1 , Curt Tysk  1 , Scott Montgomery  2   3   4 , Jonas Halfvarson  1
Affiliations

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study

Carl Eriksson et al. Aliment Pharmacol Ther. 2018 Sep.

Abstract

Background: The incidence and short-term outcome of anaemia in inflammatory bowel disease (IBD) are largely unknown.

Aim: To determine the incidence, prevalence and clinical outcome of anaemia in terms of resolution of anaemia within 12 months. We also planned to assess risk factors for anaemia in IBD.

Methods: A random sample of 342 patients was obtained from the population-based IBD cohort of Örebro University Hospital, Sweden, consisting of 1405 patients diagnosed between 1963 and 2010. Haemoglobin measurements recorded from 1 January 2011 to 31 December 2013 were extracted from the Clinical Chemistry data system.

Results: In Crohn's disease, the incidence rate of anaemia was 19.3 (95% CI: 15.4-23.7) per 100 person-years and the prevalence was 28.7% (CI: 22.0-36.2), compared with 12.9 (CI: 9.8-16.5) and 16.5% (CI: 11.2-22.9) for ulcerative colitis. Crohn's disease was associated with an increased incidence (OR = 1.60; CI: 1.02-2.51) and prevalence of anaemia (OR = 2.04; CI: 1.20-3.46) compared to ulcerative colitis. Stricturing disease phenotype in Crohn's disease (HR = 2.59; CI: 1.00-6.79) and extensive disease in ulcerative colitis (HR = 2.40; CI: 1.10-5.36) were associated with an increased risk of anaemia. Despite a higher probability of receiving specific therapy within 3 months from the diagnosis of anaemia, Crohn's disease patients had a worse outcome in terms of resolution of anaemia within 12 months (56% vs 75%; P = 0.03).

Conclusions: Anaemia is a common manifestation of IBD even beyond the first years after the diagnosis of IBD. Crohn's disease is associated with both an increased risk and a worse outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan‐Meier plot showing the cumulative probability of anaemia in patients with Crohn's disease and ulcerative colitis
See this image and copyright information in PMC

References

    1. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population‐based study. Am J Gastroenterol. 2001;96:1116‐1122. - PubMed
    1. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110‐119. - PubMed
    1. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:250‐255. - PubMed
    1. Danese S, Hoffman C, Vel S, et al. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey. Eur J Gastroenterol Hepatol. 2014;26:1385‐1391. - PubMed
    1. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190‐1197. - PMC - PubMed

Publication types

MeSH terms